0001209191-23-040285.txt : 20230630
0001209191-23-040285.hdr.sgml : 20230630
20230630160024
ACCESSION NUMBER: 0001209191-23-040285
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230628
FILED AS OF DATE: 20230630
DATE AS OF CHANGE: 20230630
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: THEUER CHARLES
CENTRAL INDEX KEY: 0001631338
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50549
FILM NUMBER: 231061548
MAIL ADDRESS:
STREET 1: C/O TRACON PHARMACEUTICALS, INC.
STREET 2: 4350 LA JOLLA VILLAGE DRIVE, SUITE 800
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc.
CENTRAL INDEX KEY: 0001260990
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 621715807
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 230
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 434-1113
MAIL ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 230
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: GTX INC /DE/
DATE OF NAME CHANGE: 20030822
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-28
0
0001260990
Oncternal Therapeutics, Inc.
ONCT
0001631338
THEUER CHARLES
12230 EL CAMINO REAL, SUITE 230
SAN DIEGO
CA
92130
1
0
0
0
0
Stock Options
0.3553
2023-06-28
4
A
0
25000
0.00
A
2033-06-28
Common Stock
25000
25000
D
One-twelfth of the number of shares subject to the option vest and become exercisable in substantially equal installments on each monthly anniversary of the grant date, subject to the Reporting Person's continued service through such vesting date.
/s/Chase C. Leavitt, Attorney-in-fact
2023-06-30